BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 332359)

  • 1. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance.
    Byrne GE
    Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic surface markers in non-Hodgkin's lymphomas.
    Cossman J; Schnitzer B; Deegan MJ
    Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomorphologic characteristics of non-Hodgkin's lymphoma.
    Bizjak-Schwarzbartl M
    Acta Cytol; 1988; 32(2):216-20. PubMed ID: 2450436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-hodgkin's lymphomas in Saskatchewan: a clinicopathologic study.
    Cherian T; Skinnider LF; Wright JL; Komjathy G
    Can Med Assoc J; 1978 Sep; 119(5):435-41. PubMed ID: 356951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphoma in children.
    Pinkel D; Johnson W; Aur RJ
    Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human malignant lymphomas in vitro. Characterization of biopsy cells and establishment of permanent cell lines.
    Sundström C; Nilsson K
    Acta Pathol Microbiol Scand A; 1978 Mar; 86(2):173-84. PubMed ID: 211794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ; Frizzera G; Kersey JH; Goldman AI
    N Engl J Med; 1979 Sep; 301(10):512-8. PubMed ID: 313510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Lancet; 1976 Dec; 2(7999):1330-3. PubMed ID: 63805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
    Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
    Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of non-Hodgkin's lymphomas of 210 patients with nodular and favorable histologies--report of the Japanese Lymphoma Radiation Therapy Study Group].
    Hayabuchi N; Jinguu K; Masaki N; Horiuchi J; Niibe H; Morita K; Watanabe S; Kaneta K
    Gan No Rinsho; 1988 Apr; 34(5):589-98. PubMed ID: 3290531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin's lymphomata: clinical features in relation to histology.
    Van Unnik JA; Breur K; Burgers JM; Cleton F; Hart AA; Kroese WF; Somers R; Van Turnhout JM
    Br J Cancer Suppl; 1975 Mar; 2():201-7. PubMed ID: 1101918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification.
    Sakata K; Satoh M; Someya M; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
    Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.